The Pfizer/ BioNTech jointly developed COVID-19 vaccine appeared to prevent the vast majority of recipients in Israel from being infected, Bloomberg reports after seeing a copy of a draft publication that was posted on Twitter and confirmed by a person familiar with the latest Israeli study.
Key takeaways
“The vaccine, which is being rolled out in a national immunization program that began Dec. 20, was 89.4% effective at preventing laboratory-confirmed infections.”
“If confirmed, the early results on lab-tested infections are encouraging because they indicate the vaccine may also prevent asymptomatic carriers from spreading the virus that causes Covid-19.“
“Israeli authorities on Saturday said the Pfizer-BioNTech shot was 99% effective at preventing deaths from the virus.”
Share
